Enveric Biosciences Stock Forecast

Sell candidate since May 11, 2026 Loss -46.62%

The Enveric Biosciences, Inc. stock price gained 8.70% on the last trading day (Wednesday, 1st Jul 2026), rising from $1.38 to $1.50. During the last trading day the stock fluctuated 6.38% from a day low at $1.41 to a day high of $1.50. The price has been going up and down for this period, and there has been a 9.49% gain for the last 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 62 thousand more shares were traded than the day before. In total, 130 thousand shares were bought and sold for approximately $194.53 thousand.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -31.76% during the next 3 months and, with a 90% probability hold a price between $0.107 and $2.72 at the end of this 3-month period.

ENVB Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Enveric Biosciences, Inc. has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. Higher liquidity also reduces the general risk. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Enveric Biosciences, Inc. stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $1.83. On a fall, the stock will find some support from the short-term average at $1.37. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. A sell signal was issued from a pivot top point on Tuesday, April 28, 2026, and so far it has fallen -71.80%. Further fall is indicated until a new bottom pivot has been found.

Support, Risk & Stop-loss for Enveric Biosciences, Inc. stock

Enveric Biosciences, Inc. finds support from accumulated volume at $1.48 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.0900 between high and low, or 6.38%. For the last week, the stock has had daily average volatility of 9.64%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (ENVB) For The Upcoming Trading Day Of Thursday 2nd

For the upcoming trading day on Thursday, 2nd we expect Enveric Biosciences, Inc. to open at $1.47, and during the day (based on 14 day Average True Range), to move between $1.40 and $1.60, which gives a possible trading interval of +/-$0.195 (+/-13.91%) up or down from last closing price. If Enveric Biosciences, Inc. takes out the full calculated possible swing range there will be an estimated 13.91% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $1.48 (1.33%) than the resistance at $1.53 (2.00%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Enveric Biosciences, Inc. stock A Buy?

Enveric Biosciences, Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. We have upgraded our analysis conclusion for this stock since the last evaluation from a Strong Sell to a Sell candidate.

Current score: -4.958 Sell Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on July 2, 2026 - $1.47 ( 2.00%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk